Generic Drugmakers Will Benefit From China’s Low-Cost Drug List

Washington Drug Letter
A A
Chinese authorities are gearing up to keep the cost of certain drugs sold in the country down via publication of a “low-cost” drug list expected to expand access to generics.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00